Earnings Call · Q1 FY2023·2023-05-02

Q1 23EPS +17.86%·Rev n/aQ4 22EPS +36.21%·Rev n/aQ3 22EPS +100.00%*·Rev n/aQ2 22EPS -9.52%·Rev n/a⚠ consensus missing

Harmony Biosciences Holdings, Inc. HRMY

Luis Sanay — Investor Relations

Jeffrey Dayno — Chief Executive Officer

Jeffrey Dierks — Chief Commercial Officer

Sandip Kapadia — Chief Financial Officer

+2.4%1d on move date+3.5% vs SPY3d+8.5%5d+10.0%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more HRMY calls or request research access.

More HRMY calls Browse calls Request research access